Drug Testing and Analysis

Article	Citations
	71
Issue Information	54
Issue Information	53
	50
	47
Identification of Hexahydrocannabiphorol Metabolites in Human Urine	38
Infant exposure to drugs of abuse investigated by hair analysis	36
Issue Information	35
Hair EtG Testing in Combination With Measurements of PEth and EtG in Blood to Improve the Assessment of Alcohol Consumption	33
Cost Minimized Immunoaffinity Purification of EPO and Its Analogs in Doping Control—A Step‐by‐Step Protocol for Human Urine and Blood	32
Annual Banned‐Substance Review 17th Edition—Analytical Approaches in Human Sports Drug Testing 2023/2024	31
Cover Picture	29
Dr. Alan Malcolm Duffield	28
Emerging Human Medications in Racing Animals: Analytical and Regulatory Challenges	28
Electrophoretic detection of black market myostatin propeptide	27
Carfentanil structural analogs found in street drugs by paper spray mass spectrometry and their characterization by high‐resolution mass spectrometry	25
Presence of β2‐agonist growth promoters in human urine samples: GC‐MS/MS evaluation of the excretion profiles of ractopamine administered in microdoses	25
Assay validation for vilanterol and its metabolites in human urine with application for doping control analysis	23
In vitro metabolite identification of acetylbenzylfentanyl, benzoylbenzylfentanyl, 3‐fluoro‐methoxyacetylfentanyl, and 3‐phenylpropanoylfentanyl using LC‐QTOF‐HRMS together with synthesized references	23
UHPLC–MS/MS method for the quantification of ultra‐traces of irinotecan and its metabolites in red blood cells and plasma to detect caregivers' contamination	22
Advances in the detection of growth hormone releasing hormone synthetic analogs	21
Does a hair test allow discriminating a tail end of a doping regimen from a contamination in case of challenging an anti‐doping rule violation? II. Case report involving chlortalidone	21
In vitro metabolism of the REV‐ERB agonist SR‐9009 and subsequent detection of metabolites in associated routine equine plasma and urine doping control samples	21
Long‐term monitoring of IOX4 in horse hair and its longitudinal distribution with segmental analysis using liquid chromatography/electrospray ionization Q Exactive high‐resolution mass spectrometry fo	21
Development and validation of a fast ultra‐high‐performance liquid chromatography tandem mass spectrometry method for determining carbonic anhydrase inhibitors and their metabolites in urine and hair	21

Advances in cocaine signature methodology: Alkaloid and isotope profiles of coca grown in Puno, Peru	20
Detection of de‐N‐glycosylated EPO with SDS‐PAGE: A complementary confirmation procedure for recombinant EPO in blood samples	20
Structure elucidation of the novel synthetic cannabinoid Cumyl‐Tosyl‐Indazole‐3‐Carboxamide (Cumyl‐TsINACA) found in illicit products in Germany	19
Evaluation of RapidSTAT®, DrugWipe® 6S, DrugScreen® 5TK and DrugScreen® 7TR for on‐site drug testing in German police roadside traffic patrol	19
Quantitative analysis of nonsteroidal anti‐inflammatory drugs in dried blood spot from mountain ultra‐trail runners. Contribution of pharmacokinetic models for the interpretation of the results	18
Identification and Investigation of the Intrinsic Receptor Activation Potential and Metabolization of the New Oxo‐Pyridyl Synthetic Cannabinoid Receptor Agonist CH‐FUBBMPDORA	18
Characterization of the lysergic acid diethylamide analog, 1‐(thiophene‐2‐carbonyl)‐N,N‐diethyllysergamide (1T‐LSD) from a blotter product	18
A direct analysis method using sheath flow probe electrospray ionisation‐mass spectrometry (sfPESI‐MS) to detect drug residues from fingerprint forensic gel lifts	18
Absence of new psychoactive substances in wastewater from South Wales, UK, revealed by optimised liquid chromatography‐time‐of‐flight analysis	18
Detection of extracellular hemoglobin from Arenicola marina in doping control serum samples by means of liquid chromatography and high‐resolution tandem mass spectrometry	17
Stability of drugs of abuse in synthetic oral fluid investigated using a simple “dilute and inject” method of analysis	16
Indirect biomarkers of blood doping: A systematic review	16
Measurements of hydrocortisone and cortisone for longitudinal profiling of equine plasma by liquid chromatography–tandem mass spectrometry	16
Effects of new anti‐doping measures on sports performance in elite female athletes	16
Annual banned‐substance review: Analytical approaches in human sports drug testing 2020/2021	16
New Transcriptomic Biomarkers for Detection of the Recombinant Human Erythropoietin (rHuEPO) MirCERA in Horses	16
Minor red blood cell antigen phenotyping of athletes sampled in international competitions	15
Cross reactivity of the CEDIA and HEIA benzodiazepine kits for 29 designer benzodiazepines and tofisopam	15
Metabolic Characterization of Vamorolone in Human Liver Microsomes: Implications for Anti‐Doping	15
Cannabinoid receptor activation potential of the next generation, generic ban evading OXIZID synthetic cannabinoid receptor agonists	15
The athletic characteristics of Olympic sports to assist anti‐doping strategies	15
Discrepancies between the stated contents and analytical findings for electronic cigarette liquid products: Identification of the new cannabinoid, Δ9‐tetrahydrocannabihexol acetate	14
Cover Picture	14
Interest of Hair Tests to Discriminate a Tail End of a Voluntary Doping Regimen From the Use of a Contaminated Medicine in Case of Challenging an Antidoping Rule Violation. VI. Case Example With Trime	14
Detection of methandienone and its metabolites in equine urine, plasma and hair following a multidose oral administration	14
	14
Identification of thermolabile positional isomers of N‐(2‐hydroxybenzyl)‐2‐(dimethoxyphenyl)ethanamines (NBOH series) using chromatography and mass spectrometry methods	14
	14
The detection of ACTH and insulin in equine plasma by solid‐phase extraction and micro‐flow LC/MSMS	13
Mercaptans in malodorants break disulfide bridges in human serum albumin and form adducts suitable as biomarkers of exposure in vitro	13
Step‐By‐Step Procedure to Identify Previously Unknown Compounds by LC‐QTOF‐MS Exemplified by an Intoxication With the Methaqualone Analog SL‐164	13
A simple approach to analysing trace metals in aerosols produced by e‐cigarettes	13
Supra‐physiological doses of anabolic androgenic steroids impact erythropoietin and blood parameters	13
Chiral separation and quantitation of methylphenidate, ethylphenidate, and ritalinic acid in blood using supercritical fluid chromatography	13
Human abuse liability assessment of e‐cigarettes: Why, what and how?	12
Issue Information	12
In vitro and in vivo metabolism of the anabolic‐androgenic steroid oxandrolone in the horse	12
Intelligence benefit of the 3‐methoxytyramine to tyramine ratio in equine urine	12
Cover Picture	12
The 23rd International Conference of Racing Analysts and Veterinarians	12
Phosphonylated tyrosine and lysine residues as biomarkers of local exposure of human hair to the organophosphorus nerve agents sarin and VX	12
Simultaneous quantification of 19 nonsteroidal anti‐inflammatory drugs in oral fluid by liquid chromatography‐high resolution mass spectrometry: Application on ultratrail runner's oral fluid	12
A fully automated method to quantitate total carbon dioxide in equine plasma by headspace GCMS	12
	12
Quantitative determination and metabolic profiling of synthetic cathinone eutylone in vitro and in urine samples by liquid chromatography tandem quadrupole time‐of‐flight mass spectrometry	12
Myostatin inhibitory peptides in sports drug testing	12
Caffeine content of energy drinks marketed in Brazil	12
Issue Information	11
Detection of bazedoxifene, a selective estrogen receptor modulator, in human urine by liquid chromatography‐tandem mass spectrometry	11
Issue Information	11

Surveillance of Anabolic Agent Residues in US Meat Supply by Liquid Chromatography With High‐Resolution Tandem Mass Spectrometry	11
An Indonesian slimming drug with undeclared ingredients causing harm	11
New gamma‐hydroxybutyric acid (GHB) biomarkers: Development and validation of a liquid chromatography–tandem mass spectrometry method for the determination of GHB amino acid, carnitine, and fatty acid	11
Cannabinoid‐based vaping products and supplement formulations reported by consumers to precipitate adverse effects	11
Determination of buprenorphine, norbuprenorphine, naloxone, and their glucuronides in urine by liquid chromatography–tandem mass spectrometry	11
Gel Electrophoretic Detection of Black Market ACE‐031	11
Administration study of recombinant erythropoietin on the carriers of variant c.577del in EPO gene	11
	11
Rapid detection of 10 benzodiazepines and metabolites in blood and urine using DART‐MS/MS	11
Equine metabolism of the growth hormone secretagogue MK‐0677 in vitro and in urine and plasma following oral administration	11
In‐depth metabolic study of nonsteroidal selective androgen receptor modulator GSK2881078 in thoroughbred horses and horse liver microsomes for doping control	10
Assessing EPO stability in urine and comparing recombinant EPO detectability in matched urine, venous serum, and capillary serum following a controlled epoetin alfa administration	10
Detection of undeclared doping substances in nutritional supplements in the context of follow‐up investigations concerning adverse analytical findings	10
Simple visualization method for the c.577del of erythropoietin variant: CRISPR/dCas9‐based single nucleotide polymorphism diagnosis	10
Implementation of a marker substance for monitoring in situ 17‐keto modifications in endogenous steroids caused by microbiological contamination	10
Drug analysis: Comparison between dried plasma spots and liquid plasma samples of trauma patients from Cameroon—A feasibility study	10
Doping control analysis of myo‐inositol trispyrophosphate and 10 bisphosphonates in equine plasma by ion chromatography–mass spectrometry and its application to clodronic acid horse administrat	10
Doping Control Analysis of Perfluorocarbons in Equine Plasma by Headspace Gas Chromatography‐Tandem Mass Spectrometry	10
A single LC‐MS/MS validated method for tulathromycin quantification in plasma, seminal plasma, and urine to be applied in a pharmacokinetic study in bull	10
Towards a robust test to detect gene doping for anabolic enhancement in human athletes	10
Detection of thyroid hormones in urine by liquid chromatography coupled to tandem mass spectrometry	10
Geographical classification of opium samples from Myanmar and Afghanistan by NMR profiling and chemometrics	10
Three cases of naloxone interference with an oxycodone immunoassay in oral fluid	10
In memoriam	9
	9
Issue Information	9
	9
A Survey of Melatonin in Dietary Supplement Products Sold in the United States	9
Metabolism of Six Novel Nitazenes in Human Liver Microsomes Based on Ultra‐High‐Performance Liquid Chromatography Coupled With High‐Resolution Mass Spectrometry	9
Metabolism of third generation synthetic cannabinoids using zebrafish larvae	9
EPO and the athlete biological passport: Hematological results from a placebo‐controlled, boosting and microdose EPO administration in male recreational athletes	9
Influence of ZnO morphology on the capability of portable paper‐based electrospray ionization mass spectrometry to determine therapeutic drugs in complex matrices	9
Chemical Analysis and Alkaloid Intake for Kratom Products Available in the United States	9
Issue Information	9
Detectability of oxandrolone, metandienone, clostebol and dehydrochloromethyltestosterone in urine after transdermal application	9
Intelligence‐based anti‐doping via an Intelligence and Drug Testing Management (IDTM) system	9
Enhanced analysis of equine plasma for the presence of recombinant human erythropoietin — Implementation of an improved workflow	9
Direct sequence confirmation of qPCR products for gene doping assay validation in horses	9
The duration of ketamine detection in hair after treatment cessation: Case study and review of the literature in forensic and clinical casework	9
Examination of the impact of myblu electronic nicotine delivery system e‐liquid nicotine strength on self‐reported measures of dependence	9
Trends in exposure to drugs and prohibited substances among sports: A nationwide analysis of 2008–2022 inquiry records	9
Performance‐enhancing substances in sport: A scientometric review of 75 years of research	9
Cover Picture	9
Interest of nail clipping tests to discriminate a tail end of a doping regimen from a contamination in case of challenging an adverse analytical finding: Case reports involving ostarine	9
Curiosity and intentions to use myblu e‐cigarettes and an examination of the ‘gateway’ theory: Data from cross‐sectional nationally representative surveys	9
Pharmacokinetics of freebase nicotine and nicotine salts following subcutaneous administration in male rats	9
Removal of the influence of plasma volume fluctuations for the athlete biological passport and stability of haematological variables in active women taking oral contraception	9
Risk of unintentional antidoping rule violations by consumption of hemp products	9
Carbon and nitrogen isotopic analysis of morphine from opium and heroin samples originating in the four major heroin producing regions	9
Frequency of new psychoactive substances in hair and urine samples of individuals subject to drug testing in driving license regranting—A toxicological perspective	8
Detection of Δ9‐tetrahydrocannabinol (THC) in oral fluid using two point‐of‐collection testing devices following oral administration of a THC and cannabidiol containing oil	8
Evaluation of Bladder Wash as an Alternative Specimen for Postmortem Toxicology: Comparison to Screening Results of Urine and Kidney Tissue	8
Optimization of Parallel Artificial Liquid Membrane Extraction for the Determination of Over 50 Psychoactive Substances in Oral Fluid Through UHPLC–MS/MS	8
Be aware of (R)‐methamphetamine: Negative immunoassay versus positive confirmation analysis	8
Metabolism study of 3‐chloromethcathinone (3‐CMC) by dried blood spot (DBS) sampling after controlled administration using a murine model	8
The use of RNA‐based 5'‐aminolevulinate synthase 2 biomarkers in dried blood spots to detect recombinant human erythropoietin microdoses	8
Characterization of 17 unknown ketamine manufacturing by‐product impurities by UHPLC‐QTOF‐MS	8
Cover Picture	8
Supercritical fluid chromatography	8
Identification of erythropoietin mimetic peptide 1 linear form in a sealed vial and its administration study in horses for doping control purpose	8
Effectiveness of blood steroidal passport markers for detecting testosterone abuse in Asians	8
Investigation of buprenorphine‐related deaths using urinary metabolite concentrations	8
Doping Control Analysis of Total Carbon Dioxide (TCO2) in Equine Plasma by Headspace Gas Chromatography–Mass Spectrometry (HS‐GC/MS)	8
Issue Information	8
Cover Picture	8
Issue Information	8
Identification of human in vitro metabolites of the haemoglobin S polymerization inhibitor voxelotor for doping control purposes	8
Detection of anabolic agents including selective androgen receptor modulators in samples outside of sport	8
An unusual detection of 2‐amino‐3‐(2‐chlorobenzoyl)‐5‐ethylthiophene and 2‐methylamino‐5‐chlorobenzophenone in illicit yellow etizolam tablets marked “5617” seized in the Republic of Ireland	8
Impact of Repeated Glucocorticoid Oral Administration on the Urinary Steroid Profile	7
Cover Picture	7
Issue Information	7
Biomarker ratios	7
Toxic plants—Detection of colchicine in a fast systematic clinical toxicology screening using liquid chromatography–mass spectrometry	7
Cover Picture	7
	7
An LC‐MS/MS method for the determination of drugs of abuse included THC‐COOH, EtG, and NPS, using a single hair extraction sample	7
Detection of Oral Testosterone Undecanoate Administration in UGT2B17 del/del and del/ins Individuals. Part II: Urinary Endogenous Steroid Sulfate Markers	7
Cover Picture	7
Acute atrazine intoxication in heifers: Case report and toxicological studies	7

Estimating human pharmacokinetic parameters for electronic nicotine delivery system products from chemical analyses of their aerosols	7
Rapid screening of 2‐benzylbenzimidazole nitazene analogs in suspect counterfeit tablets using Raman, SERS, DART‐TD‐MS, and FT‐IR	7
Analytical developments of p‐hydroxy prenylamine reference material for dope control research: Characterization and purity assessment	7
Analysis of potential phenylacetone precursors (ethyl 3‐oxo‐2‐phenylbutyrate, methyl 3‐oxo‐4‐phenylbutyrate, and ethyl 3‐oxo‐4‐phenylbutyrate) by gas chromatography/mass spectrometry and their convers	7
	7
Analytical toxicology of yew constituents in human blood and urine by liquid chromatography‐high‐resolution tandem mass spectrometry	7
Cover Picture	7
Fentanyl and Propofol Misuse: Hair Analysis Provides Significant Evidence in the Death of a Young Doctor	7
Metabolite markers for three synthetic tryptamines N‐ethyl‐N‐propyltryptamine, 4‐hydroxy‐N‐ethyl‐N‐propyltryptamine, and 5‐methoxy‐N‐ethyl‐N‐propyltryptamine	7
Doping Control of Ranitidine in Horses	7
Analysis of dried blood spots is a feasible alternative for detecting ephedrine in doping control	7
A Generic Detection Method for the Doping Control Analysis of Fc‐Fusion Proteins and Monoclonal Antibodies in Equine Plasma	7
	7
Ambient ionisation mass spectrometry for drug and toxin analysis: A review of the recent literature	7
Emergence of the less common cannabinoid Δ8‐Tetrahydrocannabinol in a doping sample	7
Analytical and behavioral characterization of 1‐hexanoyl‐LSD (1H‐LSD)	7
Comparison of Microcapillary Blood Sampling Devices for Use in Anti‐Doping	7
	7
Cover Picture	7
	7
Pitfalls in assessing the exogenous origin of GHB in hair	7
In vitro metabolic studies of novel selective androgen receptor modulators and their use for doping control analysis	7
Demonstration of an End‐To‐End Workflow Using Atmospheric Solids Analysis Probe–Mass Spectrometry (ASAP‐MS) With Real‐Time Sample Recognition Software for the Identification of Falsified and Substanda	6
Evaluation of alternative gas chromatographic and mass spectrometric behaviour of trimethylsilyl‐derivatives of non‐hydrolysed sulfated anabolic steroids	6
Quantitative analysis of tetrahydrocannabinol isomers and other toxicologically relevant drugs in blood	6
Driving license regranting: Hair EtG, serum CDT, and the role of sociodemographic and medicolegal variables	6
Hematological ABP: Interest of New Generation Sequencing Methods (NGS) to Study Suspicious Fluctuations in Erythropoiesis	6
Identification of three unexpected new psychoactive substances at an Australian drug checking service	6
Behavioral intentions assessment of a disposable e‐cigarette among adult current, former, and non‐smokers in the United States	6
A strategy for the detection of benzodiazepine drugs using low‐resolution paper‐spray mass spectrometry for harm reduction drug checking	6
Anti‐Doping Testing at FIFA World Cup 2022	6
Bayesian Individual Limits for IGF‐1 Monitoring in Equine Plasma: Implementation in the Equine Biological Passport	6
	6
Stability and detectability of testosterone esters in dried blood spots after intramuscular injections	6
Changing trends in novel benzodiazepine use within Scottish prisons: detection, quantitation, prevalence, and modes of use	6
Comparison of analytical approaches for the detection of oral testosterone undecanoate administration in men	6
Development and validation of general plasma screening method for performance enhancing drugs in racehorses utilizing liquid chromatography–high‐resolution mass spectrometry (LC–HRMS)	6
Cover Picture	6
Analytical advances in horseracing medication and doping control from 2018 to 2023	6
Drug‐impaired driving and traffic collisions: Study on a cross section of the Italian population	6
Determination of urinary deanol‐N‐oxide excretion profiles after ingestion of nutritional supplements containing deanol	6
Introduction of a PEGylated EPO conjugate as internal standard for EPO analysis in doping controls	6
Analysis of Testosterone Esters in Serum and DBS Samples—Results From an Interlaboratory Study	6
Determination of amphetamine enantiomers in urine by conductive vial electromembrane extraction and ultra‐high performance supercritical fluid chromatography tandem mass spectrometry	6
The 41st Manfred Donike workshop on doping analysis	6
External hair contamination from cannabis and “light cannabis” delivered by smoking and vaping: An in vitro study	6
Rapid desorption and analysis for illicit drugs and chemical profiling of fingerprints by SICRIT ion source	6
Cover Picture	6
Return of the lysergamides. Part VII: Analytical and behavioural characterization of 1‐valeroyl‐d‐lysergic acid diethylamide (1V‐LSD)	6
Automated enzymatic hydrolysis of urine samples for improved systematic toxicological analysis of drug‐facilitated sexual assault cases	6
Rapid and Accurate Identification of Fentanyl and Buprenorphine in Transdermal Patches Using QuickProbe GC–MS	6
Impurity profiling of methamphetamine synthesised from α‐phenylacetoacetonitrile (APAAN)	6
Microsampling: A role to play in Covid‐19 diagnosis, surveillance, treatment and clinical trials	6
Issue Information	5
Application to several suspected poisoning cases of a validated analytical method for the determination of muscarine in human biological matrices using liquid chromatography with high‐resolution mass	5
Comment on the upper cutoff level for the alcohol biomarker phosphatidylethanol (PEth) for the assessment of alcohol consumption in forensic practice	5
Structure identification and analysis of the suspected chemical precursor of 2‐fluorodeschloroketamine and its decomposition products	5
Do dried blood spots have the potential to support result management processes in routine sports drug testing?—Part 3: LC–MS/MS‐based peptide analysis for dried blood spot sampling time point estimati	5
Sequence determination of phosphorothioated oligonucleotides using MALDI‐TOF mass spectrometry for controlling gene doping in equestrian sports	5
Withdrawn: Liquid chromatography–tandem mass spectrometry and confirmation by liquid chromatography–high‐resolution mass spectrometry hair tests to evidence use of tizanidine by racing cyclists	5
Tentative identification of in vitro metabolites of O‐acetylpsilocin (psilacetin, 4‐AcO‐DMT) by UHPLC‐Q‐Orbitrap MS	5
Methylation of phase II metabolites of endogenous anabolic androgenic steroids to improve analytical performance	5
Procollagen type III amino‐terminal propeptide and insulin‐like growth factor I as biomarkers of growth hormone administration	5
Alkylated glutamic acid and histidine derived from protein‐adducts indicate exposure to sulfur mustard in avian serum	5
Improved separation of fentanyl isomers using metal cation adducts and high‐resolution ion mobility‐mass spectrometry	5
Rapid Analytical Method for Quantification of Gamma‐Hydroxybutyrate (GHB) in Hair by UPLC‐MS/MS	5
Issue Information	5
Quantitative determination of R/S‐methadone in human serum using ultra‐high performance supercritical fluid chromatography‐tandem mass spectrometry: A method for routine use	5
	5
Key challenges for in vitro testing of tobacco products for regulatory applications: Recommendations for dosimetry	5
Log D7.4 and plasma protein binding of synthetic cannabinoid receptor agonists and a comparison of experimental and predicted lipophilicity	5
Identification of equine in vitro metabolites of seven non‐steroidal selective androgen receptor modulators for doping control purposes	5
	5
Detection of activin receptor type IIA and IIB‐Fc fusion proteins by automated capillary immunoassay	5
Issue Information	5
Retrospective Evaluation of Novel Synthetic Opioids and Xylazine Chronic Intake by Post‐Mortem Hair Testing	5
Impurity profiling of methamphetamine synthesized from methyl α‐acetylphenylacetate	5
The Society of Hair Testing consensus on general recommendations for hair testing and drugs of abuse testing in hair	5
Consensus for the use of the alcohol biomarker phosphatidylethanol (PEth) for the assessment of abstinence and alcohol consumption in clinical and forensic practice (2022 Consensus of Basel)	5
Confidence in nicotine for tobacco harm reduction—Bridging the policy–practice gap	5
Acute psychotropic, autonomic, and endocrine effects of 5,6‐methylenedioxy‐2‐aminoindane (MDAI) compared with 3,4‐methylenedioxymethamphetamine (MDMA) in human volunteers: A self‐administration study	5
Estimation of anti‐diabetes drug metformin in Turkiye using wastewater‐based epidemiology	5
Ketoprofen in horses: Metabolism, pharmacokinetics, and effects on inflammatory biomarkers	5
Low‐copy transgene detection using nested digital polymerase chain reaction for gene‐doping control	5
Detection of pharmaceuticals in “dirty sprite” using gas chromatography and mass spectrometry	5
Metabolism of highly potent synthetic opioid nitazene analogs: N‐ethyl‐N‐(1‐glucuronyloxyethyl) metabolite formation and degradation to N‐desethyl metabolites during enzymatic hyd	5
Issue Information	5
	5
The importance of harmful and potentially harmful constituents in the implementation of the 2009 US Family Smoking Prevention and Tobacco Control Act	5
Issue Information	5
Determination of higenamine in common natural spices by ultrahigh‐performance liquid chromatography–tandem mass spectrometry	5
In vitro metabolism study of ADB‐P‐5Br‐INACA and ADB‐4en‐P‐5Br‐INACA using human hepatocytes, liver microsomes, and in‐house synthesized references	5
Determination of Hormonal Growth Promotants in Beef Using Liquid Chromatography–Tandem Mass Spectrometry	5
Ecdysterone: Possible sources of origin in urine	5
LC‐IRMS: Towards a High‐Throughput IRMS Methodology?	5